Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898]

Am Heart J. 2017 Feb:184:157. doi: 10.1016/j.ahj.2017.01.005.

¹ Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada. Electronic address: [email protected].
² Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
³ Empresa Pública de Emergencias Sanitarias, Almería, Spain.
⁴ Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium.
⁵ Centre Hospitalier de Versailles, SAMU 78 and Mobile Intensive Care Unit, Versailles, France.
⁶ Duke University Medical Centre, Duke Clinical Research Institute, Durham, NC.
⁷ Boehringer Ingelheim, Berkshire, UK.
⁸ Boehringer Ingelheim France, Reims, France.

No abstract available

Publication types